Pneumothorax in cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 4, 2011, Pages 220-225

  Flume, Patrick A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cystic fibrosis; pneumothorax; respiratory complications

Indexed keywords

DORNASE ALFA; MUTANT PROTEIN; STEROID; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACHROMOBACTER; ACTIVE CYCLE BREATHING TECHNIQUE; ADHESION; AEROBIC EXERCISE; AEROSOL; AIRWAY; AIRWAY OBSTRUCTION; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ASSISTED VENTILATION; BILEVEL POSITIVE AIRWAY PRESSURE; BRONCHIECTASIS; BRONCHOSPASM; BURKHOLDERIA; CATHETER ASPIRATION; CONSENSUS; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EPITHELIUM CELL; FORCED EXPIRATORY VOLUME; GENE MUTATION; HAEMOPHILUS INFLUENZAE; HEALTH CARE COST; HEALTH STATUS; HOSPITALIZATION; HUMAN; INFLAMMATORY CELL; INTERMITTENT PERCUSSIVE VENTILATION; LENGTH OF STAY; LUNG CLEARANCE; MORTALITY; ONSET AGE; OSCILLATING POSITIVE EXPIRATORY PRESSURE; PATHOGENESIS; PLEURA; PLEURODESIS; PNEUMOMEDIASTINUM; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SMOKING; SPIROMETRY; SPONTANEOUS PNEUMOTHORAX; SPUTUM; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT FAILURE; TUBE FEEDING;

CYSTIC FIBROSIS; HUMANS; PNEUMOTHORAX;

EID: 79958791071     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328345e1f8     Document Type: Review

References (38)

1. Cystic Fibrosis Foundation. Cystic fibrosis foundation patient registry 2008 annual data report to the center directors. Bethesda, MD; 2009.
2. Armstrong DS, Grimwood K, Carzino R, et al. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Br Med J 1995; 310:1571-1572.
3. Birrer P, McElvaney NG, Rudeberg A, et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994; 150:207-213. (Pubitemid 24209960)
4. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150:448-454. (Pubitemid 24252357)
5. Paxton DG, Scott EP. Pneumothorax: an unusual complication in fibrocystic disease. Am J Dis Child 1966; 111:311-312.
6. Mickle JE, Cutting GR. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations. Clin Chest Med 1998; 19:443-458. (Pubitemid 28421620)
7. Boucher RC. Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 2007; 261:5-16. (Pubitemid 46046468)
8. Sibley CD, Rabin H, Surette MG. Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol 2006; 1:53-61.
9. Flume PA, Strange C, Ye X, et al. Pneumothorax in cystic fibrosis. Chest 2005; 128:720-728. (Pubitemid 41140502)
10. Flume PA. Pneumothorax in cystic fibrosis. Chest 2003; 123:217-221. (Pubitemid 36126735)
11. Rich RH, Warwick WJ, Leonard AS. Open thoracotomy and pleural abrasion in the treatment of spontaneous pneumothorax in cystic fibrosis. J Pediatr Surg 1978; 13:237-242. (Pubitemid 8345256)
12. Smit HJM. Spontaneous pneumothorax: pathogenesis and treatment related aspects. Amsterdam; 1999.
13. Stowe SM, Boat TF, Mendelsohn H, et al. Open thoracotomy for pneumothorax in cystic fibrosis. Am Rev Respir Dis 1975; 111:611-617.
14. McLaughlin FJ, Matthews WJ, Streider DJ, et al. Pneumothorax in cystic fibrosis: management and outcome. J Pediatr 1982; 100:863-869. (Pubitemid 12123579)
15. Tomashefski JF, Bruce M, Stern RC, et al. Pulmonary air cysts in cystic fibrosis: relation of pathologic features to radiologic findings and history of pneumothorax. Hum Pathol 1985; 16:253-261. (Pubitemid 15143673)
16. Besier S, Smaczny C, von Mallinckrodt C, et al. Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J Clin Microbiol 2007; 45:168-172. (Pubitemid 46127347)
17. Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific advisory group, investigators, and coordinators of the epidemiologic study of cystic fibrosis. Chest 1999; 116:639-646. (Pubitemid 29428478)
18. Nunley DR, Ohori P, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998; 114:1321-1329. (Pubitemid 28527406)
19. Knutsen AP, Hutcheson PS, Mueller KR, Slavin RG. Serum immunoglobulins E and G anti-Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis. J Labor Clin Med 1990; 116:724-727. (Pubitemid 20378815)
20. Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010; 137:171-176.
21. Alothman GA, Alsaadi MM, Ho BL, et al. Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin. Chest 2002; 122:930-934.
22. Bense L, Eklund G, Wiman LG. Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 1987; 92:1009-1012. (Pubitemid 18026537)
23. Jansveld CA, Dijkman JH. Primary spontaneous pneumothorax and smoking. Br Med J 1975; 4:559-560.
24. Britto MT, Garrett JM, Dugliss MA, et al. Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics 1998; 101:250-256. (Pubitemid 28076658)
25. Verma A, Clough D, McKenna D, et al. Smoking and cystic fibrosis. J R Soc Med 2001; 40:29-34. (Pubitemid 32850920)
26. MacDuff A, Arnold A, Harvey J, et al. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax 2010; 65 (Suppl 2):ii18-ii31. These are the updated British Thoracic Society guidelines for the treatment of pneumothoraces. Clinical guidelines have been shown to improve clinical practice and these guidelines reinforce safer and less invasive management strategies in the light of subsequent research.
27. Flume PA. Pulmonary complications of cystic fibrosis. Respir Care 2009; 54:618-627.
28. Flume PA, Mogayzel PJ, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: pulmonary complications - hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010; 182:298-306. The CF Foundation's Pulmonary Guidelines Committee added to their list of clinical care guidelines. As there are no clinical trials from which to perform a systematic review, the Committee used the Delphi approach to reduce bias in the development of CF-specific recommendations from an expert panel.
29. Boat TF, di Sant' Agnese PA, Warwick WJ, Handwerger SA. Pneumothorax in cystic fibrosis. J Am Med Assoc 1969; 209:1498-1504.
30. Lifschitz MI, Bowman FO, Denning CR, Wylie RH. Pneumothorax as a complication of cystic fibrosis. Am J Dis Child 1968; 116:633-640.
31. MacDuff A, Tweedie J, McIntosh L, Innes JA. Pneumothorax in cystic fibrosis: prevalence and outcomes in Scotland. J Cyst Fibr 2010; 9:246-249.
32. Amin R, Noone PG, Ratjen F. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis. Cochrane Database Syst Rev 2009; 2.
33. Flume PA, Robinson KA, O'Sullivan BP, et al. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009; 54:522-537. The CF Foundation Pulmonary Guidelines Committee provided these recommendations on airway clearance therapies for patients with CF.
34. Flume PA, O'Sullivan BP, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007; 176:957-969. (Pubitemid 350127838)
35. Caronia CG, Silver P, Nimkoff L, et al. Use of bilevel positive airway pressure (BiPap) in end-stage patients with cystic fibrosis awaiting lung transplantation. Clin Pediatr 1998; 37:555-559.
36. Elkins MR, Bye PT. Inhaled hypertonic saline as a therapy for cystic fibrosis. Curr Opin Pulm Med 2006; 12:445-452. (Pubitemid 44624606)
37. Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008; 43:607-610. (Pubitemid 351813015)
38. Schidlow DV, Taussig LM, Knowles MR. Cystic fibrosis foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1993; 15:187-198.